BB BIOTECH AG - Significant Ownership

Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BB BIOTECH AG.

Significant Ownership of BB BIOTECH AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MGNX MacroGenics Inc Common Stock 15.8% $23.6M 9.93M BB Biotech AG Dec 31, 2024
AGIO Agios Pharmaceuticals, Inc. Common Stock 6.2% $112M 3.52M BB Biotech AG Dec 31, 2024
ESPR Esperion Therapeutics, Inc. Common Stock 4.9% $14.7M 9.69M BB Biotech AG Mar 4, 2025
BDTX Black Diamond Therapeutics, Inc. Common Stock 4.8% $5.14M 2.73M BB Biotech AG Mar 19, 2025
SAGE Sage Therapeutics, Inc. Common Stock 1.9% $8.72M 1.18M BB Biotech AG Jan 13, 2025

Schedules 13D/G Reported by BB BIOTECH AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.